Obama's Budget Bludgeons Big Pharma

From the impact of Obamacare to cutting-edge research, biotech buyouts to FDA decisions, The Motley Fool's health-care team sits down each week to discuss the most fascinating developments in health care, and their implications for long-term investors. In this week's edition, the team talks about a potentially landmark Supreme Court ruling, the impact of President Obama's budget on health-care stocks, the next wave of innovation for the pharma industry, and why investors need to pay attention to a small research company from upstate New York.

In the following segment, health-care analyst David Williamson takes a closer look at Obama's budget. There are definite winners and losers as the administration looks to protect certain parts of the sector while hitting others as Obamacare continues its rollout. 

What macro trend was Warren Buffett referring to when he said "this is the tapeworm that's eating at American competitiveness"? Find out in our free report: "What's Really Eating at America's Competitiveness." You'll also discover an idea to profit as companies work to eradicate this efficiency-sucking tapeworm. Just click here for free, immediate access.

Read/Post Comments (4) | Recommend This Article (5)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On April 22, 2013, at 9:15 AM, batman9999 wrote:

    The pharmaceutical industry has bludgeoned the American people for some time with exorbitantly priced drugs.

    Forty nine countries pay less than Americans for health care but live longer than we do.

  • Report this Comment On April 22, 2013, at 9:48 AM, Ronmc2 wrote:

    Yet Obama sent letters to Licensed & Permitted pot shops in Calif. to shut them down.

    Bludgeoning Big Business or Small Business-It's ALL Good when the purpose is to make people more dependent on Big Gov't.

  • Report this Comment On April 22, 2013, at 9:51 AM, evw1959 wrote:

    batman9999 - Just curious but would you care to list those 49 countries? Personally, I can't think of but one or two that I'd consider living but certainly not because their health care costs less.

  • Report this Comment On April 22, 2013, at 11:07 PM, Dadw5boys wrote:

    Since all the safe minerals and compounds have been Patented and the only new drugs that can be Patented have to have some of the Toxic minerals and compounds in them.

    I personally don't want the old drugs served up with a does of posion and be charged hig prices for it.

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2375368, ~/Articles/ArticleHandler.aspx, 9/28/2016 6:36:33 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 9 hours ago Sponsored by:
DOW 18,228.30 133.47 0.74%
S&P 500 2,159.93 13.83 0.64%
NASD 5,305.71 48.22 0.92%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/27/2016 4:02 PM
AZN $33.61 Up +0.06 +0.18%
AstraZeneca CAPS Rating: ****
HCA $75.13 Up +0.22 +0.29%
HCA Holdings CAPS Rating: ***
HMA.DL $0.00 Down +0.00 +0.00%
Health Management… CAPS Rating: No stars
LLY $80.88 Up +1.36 +1.71%
Eli Lilly and Co. CAPS Rating: ***
PFE $33.83 Up +0.19 +0.56%
Pfizer CAPS Rating: ****